chem_id	chebi_id	cas_registry	frac_id(FK)	frac_id	frac_code	moa_code	moa_name	target_code	target_site	group_name	chemical_group	common_name	resistance_risk	comments
1	CHEBI:3009	71626-11-4	1	1	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
2	CHEBI:82779	98243-83-5	2	2	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	benalaxyl-M (=kiralaxyl)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
3	CHEBI:5194	57646-30-7	3	3	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	furalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
4	CHEBI:6790	57837-19-1	4	4	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
5	CHEBI:60607	70630-17-0	5	5	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	acylalanines	metalaxyl-M (=mefenoxam)	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
6	CHEBI:81937	77732-09-3	6	6	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	oxazolidinones	oxadixyl	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
7	CHEBI:81969	58810-48-3	7	7	4	A	nucleic acids synthesis	A1	RNA polymerase I	PA - fungicides (PhenylAmides)	butyrolactones	ofurace	high	Resistance and cross resistance well known in various Oomycetes but mechanism unknown. High risk. See FRAC Phenylamide Guidelines for resistance management.	
8	CHEBI:81952	41483-43-6	8	8	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	bupirimate	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
9	CHEBI:81958	5221-53-4	9	9	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	dimethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
10	CHEBI:81989	23947-60-6	10	10	8	A	nucleic acids synthesis	A2	adenosin-deaminase	hydroxy-(2-amino-) pyrimidines	hydroxy-(2-amino-) pyrimidines	ethirimol	medium	Medium risk. Resistance and cross resistance known in powdery mildews. Resistance management required.	
11	CHEBI:5827	10004-44-1	11	11	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isoxazoles	hymexazole	unknown	Resistance not known.	
12	CHEBI:81936	26530-20-1	12	12	32	A	nucleic acids synthesis	A3	DNA/RNA synthesis (proposed)	heteroaromatics	isothiazolones	octhilinone	unknown	Resistance not known.	
13	CHEBI:138856	14698-29-4	13	13	31	A	nucleic acids synthesis	A4	DNA topoisomerase type II (gyrase)	carboxylic acids	carboxylic acids	oxolinic acid	unknown	Bactericide. Resistance known. Risk in fungi unknown. Resistance management required.	
14	CHEBI:3015	17804-35-2	14	systemic	14	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	benomyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
15	CHEBI:3392	10605-21-7	15	systemic	15	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	carbendazim	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
16	CHEBI:81926	3878-19-1	16	16	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	fuberidazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
17	CHEBI:45979	148-79-8	17	17	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	benzimidazoles	thiabendazole	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
18	CHEBI:82060	23564-06-9	18	18	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
19	CHEBI:35014	23564-05-8	19	systemic	19	1	B	mitosis and cell division	B1	ß-tubuline assembly in mitosis	MBC - fungicides (Methyl Benzimidazole Carbamates)	thiophanates	thiophanate-methyl	high	Resistance common in many fungal species. Several target site mutations, mostly E198A/G/K, F200Y in β-tubulin gene. Positive cross resistance between the group members. Negative cross resistance to N-Phenylcarbamates. High risk. See FRAC Benzimidazole Guidelines for resistance management.	
20	CHEBI:4520	87130-20-9	20	systemic	20	10	B	mitosis and cell division	B2	ß-tubulin assembly in mitosis	N-phenyl carbamates	N-phenyl carbamates	diethofencarb	high	Resistance known. Target site mutation E198K. Negative cross resistance to benzimidazoles. High risk. Resistance management required.	
21	CHEBI:82048	156052-68-5	21	21	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	benzamides	toluamides	zoxamide	low/medium	Low to medium risk. Resistance management required.	
22	CHEBI:82856	162650-77-3	22	22	22	B	mitosis and cell division	B3	ß-tubulin assembly in mitosis	thiazole carboxamide	ethylamino-thiazole-carboxamide	ethaboxam	low/medium	Low to medium risk. Resistance management required.	
23	CHEBI:7957	66063-05-6	23	23	20	B	mitosis and cell division	B4	cell division (proposed)	phenylureas	phenylureas	pencycuron	unknown	Resistance not known	
24	CHEBI:81764	239110-15-7	24	24	43	B	mitosis and cell division	B5	delocalisation of spectrin-like proteins	benzamides	pyridinylmethyl-benzamides	fluopicolide	unknown	Resistance not known	
25	CHEBI:82860	130339-07-0	25	25	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrimidinamines	pyrimidinamines	diflumetorim	unknown	Resistance not known.	
26	CHEBI:38628	129558-76-5	26	26	39	C	respiration	C1	complex I NADH Oxido-reductase	pyrazole-MET1	pyrazole-5-carboxamides	tolfenpyrad	unknown	Resistance not known.	
27	CHEBI:82052	15310-01-7	27	27	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	benodanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
28	CHEBI:81792	66332-96-5	28	28	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	flutolanil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
29	CHEBI:81823	55814-41-0	29	29	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-benzamides	mepronil	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
30	CHEBI:83065	875915-78-9	30	30	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	phenyl-oxo-ethyl thiophene amide	isofetamid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
31	CHEBI:83070	658066-35-4	31	31	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridinyl-ethyl-benzamides	fluopyram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
32	CHEBI:81994	24691-80-3	32	32	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	furan- carboxamides	fenfuram	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
33	CHEBI:3405	5234-68-4	33	systemic	33	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	carboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
34	CHEBI:7858	5259-88-1	34	34	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	oxathiin- carboxamides	oxycarboxin	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
35	CHEBI:81794	130000-40-7	35	35	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	thiazole- carboxamides	thifluzamide	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
36	CHEBI:83092	1072957-71-1	36	36	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	benzovindiflupyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
37	CHEBI:83106	581809-46-3	37	37	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	bixafen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
38	CHEBI:83113	907204-31-3	38	38	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	fluxapyroxad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
39	CHEBI:81793	123572-88-3	39	39	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	furametpyr	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
40	CHEBI:83126	881685-58-1	40	40	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	isopyrazam	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
41	CHEBI:83134	494793-67-8	41	41	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penflufen	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
42	CHEBI:81777	183675-82-3	42	42	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	penthiopyrad	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
43	CHEBI:83173	874967-67-6	43	43	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyrazole-4- carboxamides	sedaxane	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
44	CHEBI:81822	188425-85-6	44	44	7	C	respiration	C2	complex II: succinate-dehydro-genase	SDHI (Succinate dehydrogenase inhibitors)	pyridine- carboxamides	boscalid	medium/high	Resistance known for several fungal species in field populations and lab mutants. Target site mutations in sdh gene, e.g. H/Y (or H/L) at 257, 267, 272 or P225L, dependent on fungal species. Resistance management required. Medium to high risk. See FRAC SDHI Guidelines for resistance management.	
45	CHEBI:40909	131860-33-8	45	preventive, curative, and systemic	45	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	azoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
46	CHEBI:83185	850881-70-8	46	46	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	coumoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
47	CHEBI:83187	238410-11-2	47	47	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	enoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
48	CHEBI:83194	918162-02-4	48	48	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	flufenoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
49	CHEBI:83197	117428-22-5	49	49	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	picoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
50	CHEBI:83202	862588-11-2	50	50	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acrylates	pyraoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
51	CHEBI:83205	173662-97-0	51	51	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-acetamide	mandestrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
52	CHEBI:78780	175013-18-0	52	52	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyraclostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
53	CHEBI:83212	915410-70-7	53	53	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	pyrametostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
54	CHEBI:83213	902760-40-1	54	54	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	methoxy-carbamates	triclopyricarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
55	CHEBI:2962	143390-89-0	55	55	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	kresoxim-methyl	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
56	CHEBI:81833	141517-21-7	56	56	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetates	trifloxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
57	CHEBI:83218	149961-52-4	57	57	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	dimoxystrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
58	CHEBI:83220	366815-39-6	58	58	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	fenaminstrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
59	CHEBI:81831	133408-50-1	59	59	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	metominostrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
60	CHEBI:81832	248593-16-0	60	60	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oximino-acetamides	orysastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
61	CHEBI:59340	131807-57-3	61	61	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	oxazolidine-diones	famoxadone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
62	CHEBI:83253	361377-29-9	62	62	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	dihydro-dioxazines	fluoxastrobin	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
63	CHEBI:83258	161326-34-7	63	63	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	Imidazolinones	fenamidone	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
64	CHEBI:83261	799247-52-2	64	64	11	C	respiration	C3	complex III: cytochrome bc1 (ubiquinol oxidase) at Qo site (cyt b gene)	QoI-fungicides (Quinone outside Inhibitors)	benzyl-carbamates	pyribencarb	high	Resistance known in various fungal species. Target site mutations in cyt b gene (G143A, F129L) and additional mechanisms. Cross resistance shown between all members of the QoI group. High risk. See FRAC QoI Guidelines for resistance management.	
65	CHEBI:81841	120116-88-3	65	65	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	cyano-imidazole	cyazofamid	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
66	CHEBI:81846	348635-87-0	66	66	21	C	respiration	C4	complex III: cytochrome bc1(ubiquinone reductase) at Qi site	QiI - fungicides (Quinone inside Inhibitors)	sulfamoyl-triazole	amisulbrom	medium/high	Resistance risk unknown but assumed to be medium to high (mutations at target site known in model organisms). Resistance management required.	
67	CHEBI:82153	485-31-4	67	67	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	binapacryl	unknown	Resistance not known. Also acaricidal activity.	
68	CHEBI:83372	131-72-6	68	68	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	meptyldinocap	unknown	Resistance not known. Also acaricidal activity.	
69	CHEBI:83379	39300-45-3	69	69	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	dinitrophenyl crotonates	dinocap	unknown	Resistance not known. Also acaricidal activity.	
70	CHEBI:81843	79622-59-6	70	70	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	2,6-dinitro-anilines	fluazinam	low	Low risk. However, resistance claimed in Botrytis in Japan.	
71	CHEBI:81844	89269-64-7	71	71	29	C	respiration	C5	uncouplers of oxidative phos-phorylation	none	(pyr.-hydrazones)	(ferimzone)	low	Reclassified to U 14 in 2012.	
72	CHEBI:81918	900-95-8	72	72	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin acetate	low/medium	Some resistance cases known. Low to medium risk.	
73	CHEBI:35036	639-58-7	73	73	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin chloride	low/medium	Some resistance cases known. Low to medium risk.	
74	CHEBI:30473	76-87-9	74	74	30	C	respiration	C6	inhibitors of oxidative phos-phorylation, ATP synthase	organo tin compounds	tri-phenyl tin compounds	fentin hydroxide	low/medium	Some resistance cases known. Low to medium risk.	
75	CHEBI:83393	175217-20-6	75	75	38	C	respiration	C7	ATP production (proposed)	thiophene-carboxamides	thiophene-carboxamides	silthiofam	low	Resistance reported. Risk low.	
76	CHEBI:83398	865318-97-4	76	76	45	C	respiration	C8	complex III: cytochrome bc1 (ubiquinone reductase) at Qo site, stigmatellin binding sub-site	QoSI fungicides (Quinone outside Inhibitor, stigmatellin binding type)	triazolo-pyrimidylamine	ametoctradin	medium/high	Not cross resistant to QoI fungicides. Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
77	CHEBI:4045	121552-61-2	77	77	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	cyprodinil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
78	CHEBI:6751	110235-47-7	78	78	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	mepanipyrim	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
79	CHEBI:8674	53112-28-0	79	79	9	D	amino acids and protein synthesis	D1	methionine biosynthesis (proposed) (cgs gene)	AP - fungicides (Anilino-Pyrimidines)	anilino-pyrimidines	pyrimethanil	medium	Resistance known in Botrytis and Venturia, sporadically in Oculimacula . Medium risk. See FRAC Anilinopyrimidine Guidelines for resistance management.	
80	CHEBI:15353	2079-00-7	80	80	23	D	amino acids and protein synthesis	D2	protein synthesis	enopyranuronic acid antibiotic	enopyranuronic acid antibiotic	blasticidin-S	low/medium	Low to medium risk. Resistance management required.	
81	CHEBI:81419	6980-18-3	81	81	24	D	amino acids and protein synthesis	D3	protein synthesis	hexopyranosyl antibiotic	hexopyranosyl antibiotic	kasugamycin	medium	Resistance known in fungal and bacterial (P. glumae) pathogens. Medium risk. Resistance management required.	
82	CHEBI:17076	57-92-1	82	82	25	D	amino acids and protein synthesis	D4	protein synthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	streptomycin	high	Bactericide. Resistance known. High risk. Resistance management required.	
83	CHEBI:27701	79-57-2	83	83	41	D	amino acids and protein synthesis	D5	protein synthesis	tetracycline antibiotic	tetracycline antibiotic	oxytetracycline	high	Bactericide. Resistance known. High risk. Resistance management required.	
84	CHEBI:82040	124495-18-7	84	84	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	aryloxyquinoline	quinoxyfen	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
85	CHEBI:83555	189278-12-4	85	85	13	E	signal transduction	E1	signal transduction (mechanism unknown)	aza-naphthalenes	quinazolinone	proquinazid	medium	Resistance to quinoxyfen known. Medium risk. Resistance management required. Cross resistance found in Erysiphe (Uncinula) necator but not in Blumeria graminis.	
86	CHEBI:34759	74738-17-3	86	86	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fenpiclonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
87	CHEBI:81763	131341-86-1	87	87	12	E	signal transduction	E2	MAP/Histidine- Kinase in osmotic signal transduction (os-2, HOG1)	PP-fungicides (PhenylPyrroles)	phenylpyrroles	fludioxonil	low/medium	Resistance found sporadically, mechanism speculative. Low to medium risk. Resistance management required.	
88	CHEBI:3656	84332-86-5	88	88	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	chlozolinate	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
89	CHEBI:28909	36734-19-7	89	preventive, early curative, and systemic	89	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	iprodione	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
90	CHEBI:8450	32809-16-8	90	90	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	procymidone	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
91	CHEBI:9986	50471-44-8	91	91	2	E	signal transduction	E3	MAP/Histidine- Kinase in osmotic signal transduction (os-1, Daf1)	dicarboximides	dicarboximides	vinclozolin	medium/high	Resistance common in Botrytis and some other pathogens. Several mutations in OS-1, mostly I365S. Cross resistance common between the group members. Medium to high risk. See FRAC Dicarboximide Guidelines for resistance management.	
92	92	92	NA	F	lipid synthesis and membrane integrity	F1	none	formerly dicarboximides	n/a		n/a	n/a	
93	CHEBI:34735	17109-49-8	93	93	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	edifenphos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
94	CHEBI:79737	26087-47-8	94	94	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	iprobenfos (IBP)	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
95	CHEBI:81942	13457-18-6	95	95	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	phosphoro-thiolates	phosphoro-thiolates	pyrazophos	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
96	CHEBI:6047	50512-35-1	96	96	6	F	lipid synthesis and membrane integrity	F2	phospholipid biosynthesis, methyltrans-ferase	dithiolanes	dithiolanes	isoprothiolane	low/medium	Resistance known in specific fungi. Low to medium risk. Resistance management required if used for risky pathogens.	
97	CHEBI:17097	92-52-4	97	97	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	biphenyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
98	CHEBI:3628	2675-77-6	98	98	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	chloroneb	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
99	CHEBI:27864	99-30-9	99	99	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	dicloran	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
100	CHEBI:34908	82-68-8	100	100	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	quintozene (PCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
101	CHEBI:82044	117-18-0	101	101	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tecnazene (TCNB)	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
102	CHEBI:81731	57018-04-9	102	102	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	AH-fungicides (Aromatic Hydrocarbons) (chlorophenyls, nitroanilines)	aromatic hydrocarbons	tolclofos-methyl	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
103	CHEBI:81761	2593-15-9	103	103	14	F	lipid synthesis and membrane integrity	F3	lipid peroxidation (proposed)	heteroaromatics	1,2,4-thiadiazoles	etridiazole	low/medium	Resistance known in some fungi. Low to medium risk. Cross resistance patterns complex due to different activity spectra.	
104	CHEBI:83279	55406-53-6	104	104	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	iodocarb	low/medium	Low to medium risk. Resistance management required.	
105	CHEBI:82033	24579-73-5	105	105	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	propamocarb	low/medium	Low to medium risk. Resistance management required.	
106	CHEBI:82084	19622-08-3	106	106	28	F	lipid synthesis and membrane integrity	F4	cell membrane permeability, fatty acids (proposed)	carbamates	carbamates	prothiocarb	low/medium	Low to medium risk. Resistance management required.	
107	107	107	NA	F	lipid synthesis and membrane integrity	F5	none	formerly CAA-fungicides	n/a		n/a	n/a	
108	108	108	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus subtilis syn. B.amyloliquefaciens* strain QST 713	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
109	109	109	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain FZB24	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
110	110	110	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain MBI600	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
111	111	111	44	F	lipid synthesis and membrane integrity	F6	microbial disrupters of pathogen cell membranes	microbial (Bacillus sp.)	Bacillus sp. and the fungicidal lipopeptides produced	Bacillus amyloliquefaciens strain D747	unknown	*Synonyms for Bacillus amyloliquefaciens are Bacillus subtilis and B. subtilis var. amyloliquefaciens (previous taxonomic classification). Resistance not known. Induction of host plant defence described as additional mode of action for strain FZB24.	
112	CHEBI:83629	112	112	46	F	lipid synthesis and membrane integrity	F7	cell membrane disruption (proposed)	plant extract	terpene hydrocarbons and terpene alcohols	extract from Melaleuca alternifolia (tea tree)	unknown	Resistance not known	
113	CHEBI:9715	26644-46-2	113	113	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	piperazines	triforine	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
114	CHEBI:81972	88283-41-4	114	114	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrifenox	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
115	CHEBI:83823	847749-37-5	115	115	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyridines	pyrisoxazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
116	CHEBI:4998	60168-88-9	116	116	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	fenarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
117	CHEBI:7645	63284-71-9	117	117	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	pyrimidines	nuarimol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
118	CHEBI:81927	35554-44-0	118	118	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	imazalil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
119	CHEBI:83832	134074-64-9	119	119	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	oxpoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
120	CHEBI:81775	101903-30-4	120	120	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	pefurazoate	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
121	CHEBI:8434	67747-09-5	121	121	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	prochloraz	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
122	CHEBI:81784	68694-11-1	122	122	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	imidazoles	triflumizole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
123	CHEBI:81898	60207-31-0	123	123	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	azaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
124	CHEBI:3130	55179-31-2	124	124	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bitertanol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
125	CHEBI:81900	116255-48-2	125	125	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	bromuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
126	CHEBI:81758	94361-06-5	126	curative and systemic	126	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	cyproconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
127	CHEBI:81760	119446-68-3	127	127	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	difenoconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
128	CHEBI:81913	83657-18-5	128	128	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	diniconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
129	CHEBI:4811	133855-98-8	129	129	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	epoxiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
130	CHEBI:4874	60207-93-4	130	130	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	etaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
131	CHEBI:81762	114369-43-6	131	131	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fenbuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
132	CHEBI:83923	136426-54-5	132	132	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	fluquinconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
133	CHEBI:81922	85509-19-9	133	133	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flusilazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
134	CHEBI:81923	76674-21-0	134	134	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	flutriafol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
135	CHEBI:81766	79983-71-4	135	135	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	hexaconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
136	CHEBI:81767	86598-92-7	136	136	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	imibenconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
137	CHEBI:81770	125225-28-7	137	137	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	ipconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
138	CHEBI:81773	125116-23-6	138	138	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	metconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
139	CHEBI:75281	88671-89-0	139	139	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	myclobutanil	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
140	CHEBI:81970	66246-88-6	140	140	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	penconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
141	CHEBI:8489	60207-90-1	141	141	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	propiconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
142	CHEBI:81819	149508-90-7	142	142	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	simeconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
143	CHEBI:81781	107534-96-3	143	143	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tebuconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
144	CHEBI:81782	112281-77-3	144	144	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	tetraconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
145	CHEBI:9665	43121-43-3	145	145	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimefon	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
146	CHEBI:9666	55219-65-3	146	146	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triadimenol	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
147	CHEBI:81980	131983-72-7	147	147	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazoles	triticonazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
148	CHEBI:82036	178928-70-6	148	148	3	G	sterol biosynthesis in membranes	G1	C14-demethylase in sterol biosynthesis (erg11/cyp51)	DMI-fungicides (DeMethylation Inhibitors) (SBI: Class I)	triazolinthiones	prothioconazole	medium	There are big differences in the activity spectra of DMI fungicides. Resistance is known in various fungal species. Several resistance mechanisms are known incl. target site mutations in cyp51 (erg 11) gene, e.g. V136A, Y137F, A379G, I381V; cyp51 promotor; ABC transporters and others. Generally wise to accept that cross resistance is present between DMI fungicides active against the same fungus. DMI fungicides are Sterol Biosynthesis Inhibitors (SBIs), but show no cross resistance to other SBI classes. Medium risk. See FRAC SBI Guidelines for resistance management.	
149	CHEBI:83295	91315-15-0	149	systemic	149	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	aldimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
150	CHEBI:81960	1593-77-7	150	systemic	150	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	dodemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
151	CHEBI:50145	67564-91-4	151	systemic	151	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	fenpropimorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
152	CHEBI:9700	81412-43-3	152	systemic	152	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	morpholines	tridemorph	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
153	CHEBI:81917	67306-00-7	153	systemic	153	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	fenpropidin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
154	CHEBI:83283	3478-94-2	154	154	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	piperidines	piperalin	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
155	CHEBI:9242	118134-30-8	155	systemic	155	5	G	sterol biosynthesis in membranes	G2	delta14-reductase and delta8 becomes delta7-isomerase in sterol biosynthesis (erg24, erg2)	amines (“morpholines”) (SBI: Class II)	spiroketal-amines	spiroxamine	low/medium	Decreased sensitivity for powdery mildews. Cross resistance within the group generally found but not to other SBI classes. Low to medium risk. See FRAC SBI Guidelines for resistance management.	
156	CHEBI:81853	126833-17-8	156	locally systemic	156	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	hydroxyanilides	fenhexamid	low/medium	Low to medium risk. Resistance management required.	
157	CHEBI:83327	473798-59-3	157	157	17	G	sterol biosynthesis in membranes	G3	3-keto reduc-tase, C4- de-methylation (erg27)	(SBI: Class III)	amino-pyrazolinone	fenpyrazamine	low/medium	Low to medium risk. Resistance management required.	
158	CHEBI:81736	88678-67-5	158	systemic	158	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	thiocarbamates	pyributicarb	unknown	Resistance not known, fungicidal and herbicidal activity	
159	CHEBI:7451	65472-88-0	159	various	159	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	naftifine	unknown	Medical fungicides only	
160	CHEBI:9448	91161-71-6	160	various	160	18	G	sterol biosynthesis in membranes	G4	squalene-epoxidase in sterol biosynthesis (erg1)	(SBI class IV)	allylamines	terbinafine	unknown	Medical fungicides only	
161	CHEBI:29703	37248-47-8	161	161	26	H	cell wall biosynthesis	H3	trehalase and inositol-biosynthesis	glucopyranosyl antibiotic	glucopyranosyl antibiotic	validamycin	unknown	Resistance not known	
162	CHEBI:26194	11113-80-7	162	162	19	H	cell wall biosynthesis	H4	chitin synthase	polyoxins	peptidyl pyrimidine nucleoside	polyoxin	medium	Resistance known. Medium risk. Resistance management required.	
163	CHEBI:81848	110488-70-5	163	163	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	dimethomorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
164	CHEBI:83428	211867-47-9	164	164	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	flumorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
165	CHEBI:83663	868390-90-3	165	165	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	cinnamic acid amides	pyrimorph	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
166	CHEBI:83601	413615-35-7	166	166	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	benthiavalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
167	CHEBI:82023	140923-17-7	167	167	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	iprovalicarb	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
168	CHEBI:83610	283159-90-0	168	168	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	valinamide carbamates	valifenalate	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
169	CHEBI:81802	374726-62-2	169	169	40	H	cell wall biosynthesis	H5	cellulose synthase	CAA-fungicides (Carboxylic Acid Amides)	mandelic acid amides	mandipropamid	low/medium	Resistance known in Plasmopara viticola but not in Phytophthora infestans. Cross resistance between all members of the CAA group. Low to medium risk. See FRAC CAA Guidelines for resistance management	
170	CHEBI:47617	27355-22-2	170	170	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	isobenzo-furanone	fthalide	unknown	Resistance not known	
171	CHEBI:45141	57369-32-1	171	171	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	pyrrolo-quinolinone	pyroquilon	unknown	Resistance not known	
172	CHEBI:81783	41814-78-2	172	172	16.1	I	melanin synthesis in cell wall	I1	reductase in melanin biosynthesis	MBI-R (Melanin Biosynthesis Inhibitors – Reductase)	triazolobenzo-thiazole	tricyclazole	unknown	Resistance not known	
173	CHEBI:3434	104030-54-8	173	173	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	cyclopropane-carboxamide	carpropamid	medium	Resistance known. Medium risk. Resistance management required.	
174	CHEBI:3434	139920-32-4	174	174	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	carboxamide	diclocymet	medium	Resistance known. Medium risk. Resistance management required.	
175	CHEBI:3434	115852-48-7	175	175	16.2	I	melanin synthesis in cell wall	I2	dehydratase in melanin biosynthesis	MBI-D (Melanin Biosynthesis Inhibitors – Dehydratase)	propionamide	fenoxanil	medium	Resistance known. Medium risk. Resistance management required.	
176	CHEBI:3434	135158-54-2	176	176	P1	P	host plant defence induction	P1	salicylic acid pathway	benzo-thiadiazole BTH	benzo-thiadiazole BTH	acibenzolar-S-methyl	unknown	Resistance not known	
177	CHEBI:3434	27605-76-1	177	177	P2	P	host plant defence induction	P2	none	benzisothiazole	benzisothiazole	probenazole (also antibacterial and antifungal activity)	unknown	Resistance not known	
178	CHEBI:81825	223580-51-6	178	178	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	tiadinil	unknown	Resistance not known	
179	CHEBI:83657	224049-04-1	179	179	P3	P	host plant defence induction	P3	none	thiadiazole-carboxamide	thiadiazole-carboxamide	isotianil	unknown	Resistance not known	
180	CHEBI:6364	9008-22-4	180	180	P4	P	host plant defence induction	P4	none	natural compound	polysaccharides	laminarin	unknown	Resistance not known	
181	CHEBI:6364	181	181	P5	P	host plant defence induction	P5	none	plant extract	complex mixture, ethanol extract	extract from Reynoutria sachalinensis (giant knotweed)	unknown	Resistance not known	
182	CHEBI:81788	57966-95-7	182	182	27	U	unknown	U1	unknown	cyanoacetamide-oxime	cyanoacetamide-oxime	cymoxanil	low/medium	Resistance claims described. Low to medium risk. Resistance management required.	
183	CHEBI:84033	39148-24-8	183	183	33	U	unknown	U2	unknown	phosphonates	ethyl phosphonates	fosetyl-Al	low	Few resistance cases reported in few pathogens. Low risk	
184	CHEBI:44976	13598-36-2	184	184	33	U	unknown	U2	unknown	phosphonates	phosphorous acid and salts	phosphorous acid and salts	low	Few resistance cases reported in few pathogens. Low risk	
185	CHEBI:83341	76280-91-6	185	185	34	U	unknown	U3	unknown	phthalamic acids	phthalamic acids	teclofthalam (Bactericide)	unknown	Resistance not known	
186	CHEBI:83335	72459-58-6	186	186	35	U	unknown	U4	unknown	benzotriazines	benzotriazines	triazoxide	unknown	Resistance not known	
187	CHEBI:81801	106917-52-6	187	187	36	U	unknown	U5	unknown	benzene-sulfonamides	benzene-sulfonamides	flusulfamide	unknown	Resistance not known	
188	CHEBI:81759	62865-36-5	188	188	37	U	unknown	U6	unknown	pyridazinones	pyridazinones	diclomezine	unknown	Resistance not known	
189	CHEBI:81933	66952-49-6	189	189	42	U	unknown	U7	unknown	thiocarbamate	thiocarbamate	methasulfocarb	unknown	Resistance not known	
190	CHEBI:81797	180409-60-3	190	190	U6	U	unknown	U6	unknown	phenyl-acetamide	phenyl-acetamide	cyflufenamid	unknown	Resistance in Sphaerotheca. Resistance management required	
191	CHEBI:83345	220899-03-6	191	191	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzophenone	metrafenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
192	CHEBI:83346	688046-61-9	192	192	U8	U	unknown	U8	actin disruption (proposed)	aryl-phenyl-ketone	benzoylpyridine	pyriofenone	medium	Less sensitive isolates detected in wheat powdery mildew. Medium risk. Resistance management required.	
193	CHEBI:74889	2439-10-3	193	193	U12	U	unknown	F7	cell membrane disruption (proposed)	guanidines	guanidines	dodine	low/medium	Resistance known in Venturia inaequalis. Low to medium risk. Resistance management recommended.	
194	CHEBI:83277	958647-10-4	194	194	U13	U	unknown	U13	unknown	thiazolidine	cyano-methylene-thiazolidine	flutianil	unknown	Resistance not known	
195	CHEBI:81844	89269-64-7	195	195	U14	U	unknown	U14	unknown	pyrimidinone-hydrazones	pyrimidinone-hydrazones	ferimzone	unknown	Resistance not known. Reclassified from C5 in 2012.	
196	CHEBI:83268	1003318-67-9	196	196	U15	U	unknown	U15	oxysterol binding protein (OSBP) inhibition (proposed)	piperidinyl- thiazole-isoxazolines	piperidinyl-thiazole-isoxazolines	oxathiapiprolin	medium/high	Resistance risk assumed to be medium to high (single site inhibitor). Resistance management required.	
197	CHEBI:83266	376645-78-2	197	197	U16	U	unknown	U16	complex III: cytochrome bc1, unknown binding site (proposed)	4-quinolyl-acetate	4-quinolyl-acetate	tebufloquin	medium	Not cross resistant to QoI. Resistance risk unknown but assumed to be medium. Resistance management required.	
198	198	198	NC	N	not classified	NC	unknown	diverse	diverse	mineral oils, organic oils, potassium bicarbonate, material of biological origin	unknown	Resistance not known	
199	7440-50-8	199	199	M1	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	copper (different salts)	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
200	CHEBI:17909	7704-34-9	200	200	M2	M	multi-site contact activity	M	multi-site contact activity	inorganic	inorganic	sulphur	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
201	CHEBI:5015	14484-64-1	201	201	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ferbam	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
202	CHEBI:52492	8018-01-7	202	202	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	mancozeb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
203	CHEBI:52497	12427-38-2	203	203	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	maneb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
204	CHEBI:81539	9006-42-2	204	204	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	metiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
205	CHEBI:81755	12071-83-9	205	205	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	propineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
206	CHEBI:9495	137-26-8	206	206	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	thiram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
207	CHEBI:52498	12122-67-7	207	207	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	zineb	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
208	CHEBI:79736	137-30-4	208	208	M3	M	multi-site contact activity	M	multi-site contact activity	dithiocarbamates and relatives	dithiocarbamates and relatives	ziram	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
209	CHEBI:34608	133-06-2	209	209	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captan	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
210	CHEBI:81938	2425-06-1	210	210	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	captafol	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
211	CHEBI:82019	133-07-3	211	211	M4	M	multi-site contact activity	M	multi-site contact activity	phthalimides	phthalimides	folpet	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
212	CHEBI:3639	1897-45-6	212	212	M5	M	multi-site contact activity	M	multi-site contact activity	chloronitriles (phthalonitriles)	chloronitriles (phthalonitriles)	chlorothalonil	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
213	CHEBI:74875	1085-98-9	213	213	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	dichlofluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
214	CHEBI:75182	731-27-1	214	214	M6	M	multi-site contact activity	M	multi-site contact activity	sulfamides	sulfamides	tolylfluanid	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
215	CHEBI:82843	108173-90-6	215	215	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	guazatine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
216	CHEBI:5569	13516-27-3	216	216	M7	M	multi-site contact activity	M	multi-site contact activity	guanidines	guanidines	iminoctadine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
217	CHEBI:82076	101-05-3	217	217	M8	M	multi-site contact activity	M	multi-site contact activity	triazines	triazines	anilazine	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
218	CHEBI:81842	3347-22-6	218	218	M9	M	multi-site contact activity	M	multi-site contact activity	quinones (anthraquinones)	quinones (anthraquinones)	dithianon	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
219	CHEBI:34620	2439-01-2	219	219	M10	M	multi-site contact activity	M	multi-site contact activity	quinoxalines	quinoxalines	chinomethionat / quinomethionate	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
220	CHEBI:81826	41205-21-4	220	220	M11	M	multi-site contact activity	M	multi-site contact activity	maleimide	maleimide	fluoroimide	low	Generally considered as a low risk group without any signs of resistance developing to the fungicides	
